01/12/2025
As a parent to a nano-rare disease child, I've learned that grief and hope are often intertwined, once causing emotional whiplash, but over time becoming a familiar dance.
Grief took the lead following the loss of Avery Davis, the beautiful soul who was the second patient identified to share our Avery's nano-rare genetic condition, but we held fast to the belief that the girls' contributions to defining this disease would bring comfort to families seeking diagnoses in the future, and treatments and cures to our community.
Earlier this month, hope again stood center stage, as we experienced what we truly believe to be a God Wink that we are never alone in this journey. A simple chime alerting us to a Facebook message; a name we didn't recognize, introducing herself to us as Mom to Felix, a 14 year-old, redheaded boy whose genetic testing from 11 years ago was miraculously recently updated. They had received a letter from their genetics team that included our team's publication in the neurology journal BRAIN, the first research paper published about the variant. They were told their son had the same variant as the girls in the paper - he is Patient 4. Sarah, Felix's mother, had then searched the gene , found us, and reached out!
We are excited to have Felix and his family join our tiny community. We are grateful to everyone who took a leap of faith on what we were trying to do with The Avery Project and donated to enable the research needed to define and treat this disease. You are changing lives and enabling families who have waited over a decade for a diagnosis to finally have clarity and our SPG90A community is forever grateful.